Targeting BCL2 with venetoclax is a promising therapeutic strategy for "double-proteinexpression" lymphoma with
Targeting BCL2 with venetoclax is a promising therapeutic strategy for "double-proteinexpression" lymphoma with — المؤلف: Uchida, Akiko — Haematologica 20200602
- المؤلف
- Uchida, Akiko
- النشر
- Haematologica 20200602
- الوصف
- 1417-1421 p.
- الموضوعات
- Antineoplastic Agents؛ Apoptosis؛ Bridged Bicyclo Compounds, Heterocyclic؛ Cell Proliferation؛ Gene Rearrangement؛ Humans؛ Lymphoma, Large B-Cell, Diffuse؛ Proto-Oncogene Proteins c-bcl-2